Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study)

Nakagawa M, Ikeuchi M, Morimoto M, Takechi H, Toba H, Yoshida T, Okumura K, Hino N,
Nishisho A, Tangoku A

2018.12.28